Artificial intelligence (AI) is revolutionizing gastrointestinal (GI) research, offering transformative advancements in diagnostics, drug development, and personalized medicine. AI enhances precision in endoscopic imaging, improves early cancer detection, and identifies biomarkers for targeted therapies. It streamlines clinical trials, supports drug repurposing, and utilizes real-world evidence to refine treatment protocols. AI also deepens understanding of the microbiome, unlocking therapeutic opportunities for GI disorders like IBD and colorectal cancer. With platforms like Virgo enabling real-time decision support, predictive analytics, and multimodal data integration, the future of GI research is set to achieve unprecedented breakthroughs, reshaping patient care and treatment strategies.
How AI is Transforming GI Research (Virgo)
0